$VYGR 4 SEC Filings

Filed On	Filing
11 Jun 2026	Form 4: Scangos George A, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Mackey Catherine J, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Hyman Steven, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Vitale Nancy, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Higgins Michael J, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Onyia Jude, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Geraghty James A, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Colon Grace, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Pierce Glenn, Director Granted 30,000 Stock Option (Right to Buy)
03 Apr 2026	Form 4: Sandrock Alfred, Director Sold 11,511 shares ($44.5K)
03 Apr 2026	Form 4: Shiferman Gregory L., SVP and General Counsel Received 50,000 shares as a grant or award
26 Feb 2026	Form 4: Swartz Robin, COO & CBO Sold 6,458 shares ($24.3K)
26 Feb 2026	Form 4: Sandrock Alfred, Director Sold 14,197 shares ($53.8K)
26 Feb 2026	Form 4: Jorgensen Nathan D., Chief Financial Officer Sold 4,668 shares ($17.6K)
26 Feb 2026	Form 4: Carter Todd Alfred, Chief Scientific Officer Sold 4,174 shares ($15.7K)
20 Feb 2026	Form 4: Swartz Robin, COO & CBO Sold 3,882 shares ($13.4K)
20 Feb 2026	Form 4: Carter Todd Alfred, Chief Scientific Officer Sold 3,301 shares ($11.4K)
20 Feb 2026	Form 4: Sandrock Alfred, Director Sold 11,732 shares ($40K)
11 Feb 2026	Form 4: Swartz Robin, COO & CBO Sold 4,569 shares ($17.6K)
11 Feb 2026	Form 4: Sandrock Alfred, Director Sold 12,192 shares ($46.1K)

Comments